Company Filing History:
Years Active: 1998-2000
Title: Michael Nunn: Innovator in Medical Antibody Development
Introduction
Michael Nunn is a prominent inventor based in San Diego, California. He has made significant contributions to the field of medical research, particularly in the development of antibodies for treating inflammation and other pathological conditions. With a total of two patents to his name, Nunn's work is recognized for its innovative approach to medical treatments.
Latest Patents
Michael Nunn's latest patents include a method for detecting the presence of P-selectin. This invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies. These antibodies inhibit the adhesion of leukocytes to activated platelets and/or to activated vascular endothelium in vivo. Both murine and humanized antibodies are provided in this patent. Another patent focuses on antibodies to P-selectin and their uses, further emphasizing the importance of these antibodies in medical treatments.
Career Highlights
Nunn is currently associated with Cytel Corporation, where he continues to advance his research and development efforts. His work at Cytel has positioned him as a key player in the field of antibody research, contributing to innovative solutions for complex medical issues.
Collaborations
Some of Michael Nunn's notable coworkers include Margaret J Polley and James C Paulson. Their collaborative efforts have further enhanced the research and development initiatives at Cytel Corporation.
Conclusion
Michael Nunn's contributions to the field of medical research through his innovative patents and collaborations highlight his commitment to advancing healthcare solutions. His work continues to impact the treatment of inflammation and other pathological conditions, showcasing the importance of innovation in medicine.